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Abstract
Background: In Malawi essential drugs are provided free of charge to patients at all public health
facilities in order to ensure equitable access to health care. The country thereby spends about 30%
of the national health budget on drugs. In order to investigate the level of drug shortages and
eventually find the reasons for the drugs shortages in Malawi, we studied the management of the
drug supplies for common and life threatening diseases such as pneumonia and malaria in a random
selection of health centres.
Methods: In July and August 2005 we visited eight out of a total of 37 health centres chosen at
random in the Lilongwe District, Malawi. We recorded the logistics of eight essential and widely
used drugs which according to the treatment guidelines should be available at all health centres.
Five drugs are used regularly to treat pneumonia and three others to treat acute malaria. Out-of-
stock situations in the course of one year were recorded retrospectively. We compared the
quantity of each drug recorded on the Stock Cards with the actual stock of the drug on the shelves
at the time of audit. We reviewed 8,968 Patient Records containing information on type and
amount of drugs prescribed during one month.
Results: On average, drugs for treating pneumonia were out of stock for six months during one
year of observation (median value 167 days); anti-malarial drugs were lacking for periods ranging
from 42 to138 days. The cross-sectional audit was even more negative, but here too the situation
was more positive for anti-malarial drugs. The main reason for the shortage of drugs was
insufficient deliveries from the Regional Medical Store. Benzyl penicillin was in shortest supply (4%
received). The median value for non-availability was 240 days in the course of a year. The supply
was better for anti-malarial drugs, except for quinine injections (9 %). Only 66 % of Stock Card
records of quantities received were reflected in Patient Records showing quantities dispensed.
Conclusion: We conclude that for the eight index drugs the levels of supply are unacceptable. The
main reason for the observed shortage of drugs at the health centres was insufficient deliveries
from the Regional Medical Store. A difference between the information recorded on the Stock
Cards at the health centres and that recorded in the Patient Records may have contributed to the
overall poor drug supply situation. In order to ensure equitable access to life saving drugs, logistics
in general should be put in order before specific disease management programmes are initiated.
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The effectiveness of drug supply systems in achieving a
reliable supply of essential drugs needs to be continually
and objectively assessed. The drugs management cycle
involves four basic functions: selection, procurement, dis-
tribution and use [1]. At the centre of the cycle is a core
management support system, and the entire cycle rests on
the policy and the legal framework that establishes and
supports the public commitment to ensure that essential
drugs are accessible to the intended population. Malawi,
which is mainly dependent on imported drugs, adopted
in1987 the principle of an essential drug list for the public
health sector, now containing about 384 drugs [2]. Since
then the government has intended to provide drugs free of
charge at all public health facilities. It spends $7 annually
per person on health, of which about $2 (29%) is spent
on drugs [3]. It is crucial that essential drugs actually reach
patients in need of them. However, there is evidence that
drug shortage is a major barrier to access to essential drugs
in the sub-Saharan Africa [4-6]. Many studies addressing
the barriers of access to essential drugs in developing
countries have been poorly designed and did only focus
on the prescribers' and users' perspectives and not on the
management of drugs supply systems [7]. In this study, we
investigated the management aspect of the drug supplies
for common and life threatening diseases such as pneu-
monia and malaria in Lilongwe district. We verified that
the numerous complaints and local newspaper articles
were truly reflecting the shortage of drugs used to combat
life-threatening diseases in the country. The state-control-
led supply system requires each health centre to report the
stock situation to the District Pharmacy each month. The
health centres do not have a pharmacist or pharmacy tech-
nician on the staff. The District Pharmacy, which also does
not have trained pharmacy staff, compares the reported
stock situation with a stock size guideline and sends an
order to the Regional Medical Store. After a certain time
lag, the health centre receives the drugs. The aim of our
study was to compare the real situation in the field with
the ideal situation as described in the Malawi health pol-
icy and in global recommendations.
Methods
Study design
The study design was cross sectional and retrospective.
One of the authors (NNL) visited a random selection of
health centres, recorded the quantities of the selected
drugs on the shelves and retrospectively summed up the
ordering history for the same drugs throughout the course
of one year at each centre. He also compared the stock sit-
uation with the Patient Records for one month and bal-
anced the amount of drugs dispensed with the amount
received.
Study setting and selection of the health centres
There are 27 districts in Malawi. Bearing in mind the lim-
ited finances available for the study, we concentrated our
investigations to the area of the capital city and its sur-
roundings, i.e. Lilongwe, which is situated in the centre of
the country. According to the population census of 1998,
Lilongwe district has a population of 1,337,777 with an
annual growth rate of 2.9%. About 67% of the population
live in the rural and peri-urban areas and comprises a
range of mixed races and tribes in the city and the peri-
urban areas. The rural areas are mainly inhabited by the
Chewa tribe who financially is dependent on seasonal
small scale farming of tobacco while maize is their main
source of food. The main religions in the district are Chris-
tianity and Islam with Islam being practised mainly in the
city [8]. The Lilongwe District has one Central Hospital,
37 government health centres, about eight Christian Hos-
pital Association of Malawi (CHAM) health facilities and
some private clinics. The private clinics are mainly located
in the city. Using the Research Randomizer [9] we selected
several groups of governmental health centres with eight
in each group and chose one of these groups for further
study.
Selection of the index drugs
We studied the logistics of eight essential and widely used
drugs, which according to the treatment guidelines should
be available in all health centres at all times. Of these
drugs, five are used regularly to treat pneumonia and the
three others to treat acute malaria. Both these diseases are
common and life-threatening conditions that contribute
substantially to local morbidity and mortality. The drugs
are listed in Table 1 and the units in which they are
ordered are specified. Paraldehyde is used for the manage-
ment of convulsions that sometimes occur in patients
with severe malaria, especially in children.
Data collection
Data were collected during a personal visit by NNL,
accompanied by a technical assistant, to each of the eight
health centres, after a letter of recommendation had been
sent in advance from the District Health Office. The health
centre employees were very cooperative when interviewed
about the ordering system and provided access to Stock
Cards, Drug Reports and Patient Records (see below)
which are maintained manually. We conducted nine
interviews (eight interviews with the persons in charges of
medicines at the health centres and one interview with the
pharmacist in charge) using a structured questionnaire
that contained questions on the procurement process,
inventory management, supervision, training and drug
management policy. The data obtained from the Stock
Cards, Drug Reports and Patient Records were manually
entered into standardised forms, which had been pre-
tested at a health centre other than one of the eight andPage 2 of 7
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ferred to an Excel Worksheet (Microsoft).
The drug ordering and dispensing system
The health centres initiate the drug-ordering process by
compiling monthly Drug Reports that are submitted to
the District Pharmacy. These reports contain information
on the quantities used of each drug during the previous
month and the balance in hand. The District Pharmacy
technician assesses the health centre's requirements, com-
pletes the order part of the Drug Report in accordance
with given criteria and forwards it to the Regional Medical
Stores. Malawi has three Regional Medical Stores, based in
each of the three regions in the country. Each Regional
Medical Store serves the government and CHAM health
facilities in the respective region. The Regional Medical
Store then supplies the ordered drugs directly to the
health centre. When drugs are received at the health cen-
tre, the quantity received and date of delivery are entered
on the respective Stock Cards and on the centre's own
copy of the Drug Report. Emergency supplies can also be
ordered, in which case the same procedure should be fol-
lowed as when ordering normal supplies. When drugs are
issued from the health centre store to the dispensary the
date of issue and quantity issued are recorded on the Stock
Card. Ideally, when patients receive drugs from the health
centre dispensary the quantity of each drug dispensed and
the date should be recorded in the Patient Records.
Our review of the Drugs Reports, Stock Cards and Patient Records
We reviewed the Stock Cards for each of the eight selected
drugs in order to determine the availability over a period
of one year (calculated as 360 days). The quantities of
each drug specified on the Stock Card were compared with
the actual stock on the shelves. A total of 58 Stock Cards
were reviewed at the eight health centres. Six cards were
missing. The accumulated observation time in days was
20,880 days (360 days × 58 Stock Cards). For each drug
the number of normal supplies and of emergency supplies
and the number and duration of out-of-stock situations
were recorded.
In order to assess the level of service provided by the
Regional Medical Store we reviewed 54 Drug Reports stat-
ing, both by the health centre and the Regional Medical
Store, the quantities requested and the quantities received.
Thirty eight reports were found to be eligible for determin-
ing the ability of the Regional Medical Stores to supply the
requested drugs to the health centres. In addition, we
reviewed 8 968 Patient Records containing information
on the type and quantities of drugs prescribed and issued
topatients during the month of December 2004.
Data analysis
All calculations regarding the number of days that the
drugs were out of stock, the number of normal and emer-
gency supplies received by the health centres, and drugs
delivered to patients according to the Patient Records were
carried out in Microsoft Excel. The total dosage of all the
drugs presented in tablet or capsule forms was calculated
as the product of the dose, frequency of administration
and duration of treatment. For the injectable drugs, one
vial or ampoule was regarded as the total dosage because
according to the records the patients had received the drug
in question only once. The number of days a drug was out
of stock was calculated by counting the days from the date
the drug was recorded on the Stock Card as being out of
stock to the date the drug was recorded as being in stock
again. We used the SPSS for descriptive analysis and for
comparing the distribution of the different variables
among the health centres and among the drugs. We used
the non-parametric Kruskal-Wallis test because the distri-
bution of the data was found to be non-normal. The dif-
ferences were considered to be statistically significant if
the P-value was < 0.05.
Permissions and ethical clearance
The study was approved by the National Health Sciences
Research Committee of the Ministry of Health in Malawi.
Table 1: The total amount of the eight drugs that were supplied to the eight health centres according to the 38 reports that were 
reviewed
Ordering units Number of units ordered Fraction received
Drugs for pneumonia
Amoxicillin tab 1000 × 250 mg 784 31 %
Benzyl penicillin injection One 5 mL unit vial 1525 4 %
Cotrimoxazole tab 1000 × (400 mg + 80 mg) 1018 50 %
Chloramphenicol injection 1 g sodium succinate vial 483 15 %
Erythromycin tab 1000 × 250 mg 425 21 %
Drugs for malaria
Pyrimethamine/sulfadoxine tab 1000 × (25 mg + 500 mg) 325 63 %
Paraldehyde injection One 10 mL ampoule 2167 48 %
Quinine injection One 600 mg ampoule 2100 9 %Page 3 of 7
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sion to proceed with the study. At the health centre-level,
the person in charge gave us permission to collect the
data. The data were kept confidential and all the health
centres studied were kept anonymous.
Results
It can be seen from Figure 1 that supplies of the selected
drugs to the health centres were highly inadequate, the
shortage being most pronounced for the drugs used to
treat pneumonia. On average, these drugs were out of
stock for six months during the one year of observation
(median value 167 days). The situation was slightly better
but still serious for anti-malarial drugs. On average these
drugs were out of stock for less than one third of the year
of observation (range 42 to 138 days). Figure 1 shows
similarities between the cross-sectional data (i.e. numbers
of health centres without the respective drugs on the
shelves at the time of audit) and the retrospective findings
(i.e. median numbers of days the respective drugs which
according to the store records had been out of stock dur-
ing the whole year of observation). Overall, the audit
results gave a more worrying picture than did the retro-
spective data (see Figure), but here again the situation was
somewhat better for the anti-malarial drugs than for the
drugs used to treat pneumonia.
Insufficient deliveries from the Regional Medical Store
It was found that the main reason for the observed short-
age of drugs at health centre level was insufficient deliver-
ies from the Regional Medical Store (see Table 1 and first
row in Table 2).
Of the drugs used to treat pneumonia the supply level was
lowest for benzyl penicillin, with only 4% of the
requested quantity being received (Table 1). This corre-
Deficiencies in drug supplies at 8 Malawian health centresFigur  1
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not in stock at any health centre at the time of audit, and
for all the health centres collectively the median value for
being out of stock was 240 days out of one year (see Fig-
ure).
Anti-malarial drugs were in better supply, except for qui-
nine injections where only 9 % of the ordered quantity
was received (Table 1). This figure does not correspond
with the seemingly better stock situation at the time of
audit, when quinine injections were available at five of the
eight health centres and where the median value for non-
availability was 42 days in the course of one year (Figure).
Stocked supplies not recorded as having been given to 
patients
From the 8968 Patient Records, we found that pyrimeth-
amine/sulfadoxine (first line treatment of malaria) was
the most commonly prescribed drug (60.4%) followed by
cotrimoxazole (first line treatment of pneumonia) that
was prescribed in 24.8% of all the cases. Chlorampheni-
col and paraldehyde injectables were the least prescribed
drugs (0.1%). We found discrepancies between the utili-
sation of drugs on the Stock Cards and the Patient
Records. The highest discrepancy was for chlorampheni-
col injectable (92%). The median discrepancy percentage
for all drugs was 66%. The second row in Table 2 illus-
trates the discrepancy between the quantity of the drugs
issued from the health centre stores to the dispensary and
the quantity of the drugs delivered to patients, as stated in
the Patient Records.
Uneven distribution of drugs among health centres
Uneven distribution of drugs among the health centres
may also have contributed to scarcity in some places.
According to the records, the number of days a drug was
out of stock varied from 0 to 122 days for injectable qui-
nine and from 0 to 360 days for injectable chloramphen-
icol at the various health centres. Overall there was a
statistically significant difference among the various
health centres (P = 0.02, Kruskal-Wallis test). Similarly,
the same drugs were found to be in stock at time of audit
in quantities ranging from zero ordering units for injecta-
ble chloramphenicol at five health centres to 48 units at
one health centre, and from zero ordering units of inject-
able quinine at three health centres to a maximum of 210
units at another health centre.
Time taken from ordering to receiving of drugs and lack of 
training and supervision
The time taken between ordering and receiving the drugs,
lack of appropriate skills for health workers managing
drugs and lack of supervision may also have contributed
to the shortage of drugs in the health centres. From the
drug reports, we found that drugs took 8 to 105 days from
the time of ordering to the time the drugs were actually
received by the health centre. The median delay between
ordering and supply was 37 days. Seven health centre per-
sons in charge of medicines reported that drugs were usu-
ally received more than 28 days after the day the drugs
were requested. From the interviews, we found that none
of the health workers managing drugs were trained in
basic drug management skills and that they were rarely
supervised by the district pharmacist.
Discussion
Although we expected the situation to be less than opti-
mal, it was a surprise to find that the index drugs were on
average unavailable to patients at health centres for six
months out of a year in the case of pneumonia drugs and
for three months out of a year in the case of anti-malarial
drugs. Findings on the drugs available at time of audit
agreed to a large extent with the stock situation through-
out a full year. To our knowledge, no similar investigation
has been carried out in Malawi before and we do not
know of comparable data from other sub-Saharan coun-
tries with similar distribution systems [6]. In our opinion,
since the selected health centres were a random sample
from the health centres in one specific region (Central
Region) and were served by one Regional Medical Store,
Table 2: Probable reasons for insufficient drug supplies with comments, ordered according to assumed degree of importance
Reason Comment
Insufficient deliveries from the Regional Medical Store The median fraction of the ordered drugs received by the health centres was 18 
% (see Table 1)
Stocked supplies not recorded as having been given to patients For December 2004 we observed a median difference of 66 % between Stock 
Cards and Patient Records. The highest was for chloramphenicol (92 %) and 
lowest for benzyl penicillin (29 %)
Uneven distribution of drugs among health centres Injectable drugs (quinine and chloramphenicol) were unequally distributed among 
health centres both at audit and throughout the year (see text)
Problems with certain therapeutic indications Drugs for acute malaria were in better supply than drugs for pneumonia (see 
Figure)
Lack of training None of the health workers managing the drugs in the eight health centres were 
trained in drug management nor in bookkeepingPage 5 of 7
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uation in the region as a whole. Drug shortages have been
reported to be a major problem throughout Malawi
[10,11], and as there is a national drug management sys-
tem, our findings at large may well apply to the whole
country.
The main limitation of the present study is that it was
restricted primarily to observations and interviews at the
health centre level. We noted that in four out of five
instances no drugs were supplied in response to a normal
order. So far we can only speculate on the reasons for this
situation. A point of interest is that many acute situations
may have been solved by sending an emergency order to
the District Pharmacy. This is not an ideal situation, how-
ever, since the health centre concerned then receives drugs
intended primarily for other users. We also question the
guidelines stating that the quantity of a drug ordered
should be based on the consumption during the previous
month [12]. When there are no drugs at the health centre
to consume, this is not a feasible procedure. With frequent
out-of-stock situations the requirements should be based
on demographic and morbidity data [13].
We found gross discrepancies between the Stock Cards
filled in at the health centres and the Patient Records. The
most likely explanation is that drugs are de facto dis-
pensed to patients but not recorded as such, which consti-
tutes lack of compliance with procedures. The procedures
themselves may be out of touch with real life challenges
in a busy outpatient clinic. In any case, this kind of "mal-
practice" makes it difficult to deal with allegations of theft
which, according to newspaper reports [14,15] and stud-
ies in other countries [16,17] cannot be excluded to take
place.
It is possible to envisage ways to improve the system:
training the personnel in bookkeeping combined with
supportive supervision, a type of intervention proven to
be effective in Zimbabwe [18]; decentralization of the
drug budget to the District, which might allow the Dis-
tricts to buy drugs from other sources when the govern-
ment medical store fails to supply, as was found to be the
case in Uganda [4]; and a small co-payment from patients
that can be used to replenish the supplies at health centre
level. As the Bamako initiative has proved, this increases
the availability of drugs [19].
One of our findings was an unequal distribution of the
drugs in stock among the various health centres. This may
indicate lacking focus on equitable access to essential
drugs. The intended role of the district pharmacies is to
enforce some sort of national, criteria based harmoniza-
tion. One measure could be to strengthen the district
pharmacies authority and ability to respond to such infor-
mation and to perform some kind of reallocation of drugs
when needed.
We noted that the supply of anti-malarial drugs was some-
what better than that of drugs used to treat pneumonia.
There could be various explanations for this, including the
fact that malaria, along with AIDS and tuberculosis, has
received special governmental and international attention
through the Global Fund for HIV/AIDS, Tuberculosis and
Malaria and the Roll Back Malaria Global Partnership. No
comparable initiatives exist for pneumonia, despite this
being a major killer of children [20]. We know several ini-
tiatives have been taken to provide drugs for treating AIDS
in Malawi [21]. A well-functioning drug supply system is
a critical factor for success in any disease management
program. AIDS initiatives in Malawi may well profit by or
even depend on a joint effort in reviewing and improving
the drug supply infrastructure in the country.
Conclusion
We conclude that for the index drugs, anti-malarial drugs
and drugs used to treat pneumonia, the levels of supply
are unacceptable. To a large extent these drugs were out of
stock during our visits to the various health centres and
had also been out of stock for extensive periods during the
previous year. Also the distribution level among the
health centres showed large variations, resulting in both
lack and inequity of access for patients.
The main reason for the observed shortage of drugs at
health centre level was insufficient deliveries from the
Regional Medical Store. We have not explored the reasons
for these shortcomings. On the one hand the public sector
may be procuring insufficient drugs to meet the country's
needs, on the other hand there may be a leakage of drugs
from the public sector into the private sector, such as has
been described in other countries [5,22].
We also found a consistent and large difference between
Stock Card recordings at the health centres and Patient
Records. This practice makes it difficult to exclude that
leakage or theft and may have contributed to the overall
drug supply situation. Another contributory factor may
have been the observed lack of training in core principles
of drug management as well as basic record keeping. In
order to ensure equitable access to life saving drug, logis-
tics in general should be put in order before specific dis-
ease management programmes requiring a reliable drug
supply chain are initiated.
Competing interests
The author(s) declare that they have no competing inter-
ests.Page 6 of 7
(page number not for citation purposes)
BMC Health Services Research 2007, 7:86 http://www.biomedcentral.com/1472-6963/7/86Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Authors' contributions
The reported data originate from a thesis for the Master
Degree in International Health presented by NNL to the
Faculty of Medicine, University of Oslo, in June 2006.
Details from the prescription analysis can be found in the
thesis book. Based on an original idea by NNL, all three
authors planned the study and examined the data after
they had been collected by NNL. IA drafted the manu-
script and developed it with the help of the other two
authors. All three authors have read and approved of the
final manuscript.
Acknowledgements
We sincerely thank the Norwegian Agency for Development Cooperation 
(NORAD) and the Norwegian International Health Association (NIHA) for 
financial support for this project. We would like to express our sincere 
thanks to Beatrice Mkandawire for working tirelessly during the data col-
lection and all health workers in the health centres for their cooperation 
and support, especially for providing us with the appropriate documents. 
We thank Professor Johanne Sundby, Department of International Health, 
University of Oslo for her critical comments on this study. We are also 
grateful to Professor Graham Dukes for helping to provide important liter-
ature.
References
1. Quick JD: Ensuring access to essential medicines in develop-
ing countries: a framework for action.  Clinical Pharmacology &
Therapeutics 2003, 73(4):279-283.
2. Malawi Central Medical Stores: Central Medical Stores' Cato-
logue for the year 2005 – 2006.  2005.
3. Malawi National Health Accounts: Sources of finance in the
health sector, 1998/9 financial year.   [http://www.who.int/nha/
docs/en/Malawi_NHA_report_english.pdf]. Accessed 12-4-2007.
4. Jitta J, Whyte SR, Nshakira NT: The availability of drugs: what
does it mean in Ugandan Primary Care.  Health Policy 2003,
65:167-79.
5. Foster S: Supply and use of essential drugs in Sub-Saharan
Africa: Issues and possible solutions.  Social Science and Medicine
1991, 32(11):1201-1218.
6. Qeest SV, Macwan'gi M, Kamwanga J, Mulikelela D, Mazimba A,
Mwangelwa M: User fees and drugs: What did the health
reforms achieved in Zambia?  Health Policy and Planning 2000,
15:59-65.
7. Grand AL, Hogerzeil HV, Haaijer-Ruskam FM: Intervention
research in rational use of drugs: a review.  Health Policy and
Planning 1999, 14:89-102.
8. National Statistic Office: Malawi Population and Housing Cen-
sus (1998) Final results.  2000 [http://www.nso.malawi.net].
Accessed 12-4-2007.
9. Research Randomizer  2006 [http://www.randomizer.org].
Accessed 12-4-2007.
10. Malawi Ministry of Health: Malawi National Drug Policy.
1999:1-5.
11. Malawi Ministry of Health: Annual review of the health sector
2005–2006 Financial year.  2006.
12. DELIVER: Calculating how much to order or issue.  In Malawi:
Health Commodities Logistics Management System Procedures Manual
Arlington, Va.: John Snow, Inc/DELIVER, for the U.S. Agency for Inter-
national Development; 2003. 
13. Drug management for health facilities.  In Managing Drug Supply
Edited by: Quick JD, Rankin JR, Laing RO, O'Connor RW, Hogerzeil
HV, Dukes MNG, Garnett A. Connecticut: Kumarian Press;
1997:364-77. 
14. Banda M: Impounded drugs worth millions.  2006 [http://
www.nationmalawi.com/print.asp?articleID=15810]. Accessed 12-4-
2007.
15. Nyirongo E: Man found with 27 types of drugs.  2005 [http://
www.nationmalawi.com/print.asp?articleID=13892]. Accessed 12-4-
2007.
16. Ferrinho P, Omar MC, Fernandes MJ, Blaise P, Bugalho AM, Van Ler-
berghe WV: Pilfering for survival: how health workers use
access to drugs as a coping strategy.  Human Resources for Health
2004, 2:1-6.
17. Geest SV: Self-care and the informal sale of drugs in South
Cameroon.  Social Science & Medicine 1987, 25:293-305.
18. Quick JD, Hogerzeil HV, Velasquez G, Rago L: Twenty-five years
of essential medicines.  Bulletin of the WHO 2005, 80(11):913-914.
19. Uzochukwu B, Onwujekwe O: Healthcare reform involving the
introduction of the user fees and drug revolving funds: influ-
ence on health workers' behaviour in southeast Nigeria.
Health Policy 2005, 75:1-8.
20. The International Union Against Tuberculosis and Lung Disease: Ten
facts about pneumonia in children.  2006 [http://www.iuatld.org/
pdf/en/facts_children.pdf]. Accessed 12-4-2007.
21. Kemp J, Aitken JM, LeGrand S, Mwale B: Equity in health sector
responses to HIV/AIDS in Malawi.  2003 [http://www.equineta
frica.org/bibl/docs/aidsmalawi.pdf]. Accessed 12-4-2007.
22. Hogerzeil HV: Estimating drug requirements. Standardised
supply of essential medicines in Ghana- 2.  Tropical Doctor 1986,
16:155-159.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-6963/7/86/prepubPage 7 of 7
(page number not for citation purposes)
